Ritlecitinib in Alopecia Areata: A 24‐Week Real‐World Experience Contrasting <scp>JAK</scp> Inhibitor‐Naïve and <scp>JAK</scp> Inhibitor‐Experienced Patients
Toshiki Okazaki(Tohoku University), Yoshihide Asano(Tohoku University), Moyuka Wada‐Irimada(Tohoku University), Mana Sekine(Tohoku University), Takehiro Takahashi(The University of Tokyo), Emi Yamazaki(Tohoku University), Tomoko Chiba(Tohoku University), Kosuke Shido(Tohoku University), Takuya Takahashi(Tohoku University), Toshiya Takahashi(Tohoku University)
Cited by 5
Related Papers
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
|New England Journal of Medicine|2020|1k
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets
|Nature Microbiology|2020|917